´óÏó´«Ã½ is at the forefront of changing the way donor livers are preserved in the critical time between donation and transplantation

´óÏó´«Ã½ was founded in 2008 as a spin-out from the University of Oxford to advance the normothermic perfusion technology invented by Professor Peter Friend and colleagues, and further developed by Professor Constantin Coussios.

Our first product the metra®, received CE mark approval in 2016 and FDA-approval in 2021. Since then, the metra has supported over 1,500 transplants around the world, transforming the way donor livers are preserved and assessed, and helping to ensure more livers are available for transplantation.